Q517--Contingency Chemotherapy Compounding Services for the Louis A. Johnson VA Medical Center

The contract is a five-year, fixed-price, indefinite delivery indefinite quantity (IDIQ) solicitation issued by the Department of Veterans Affairs through the Network Contract Office 5 to secure contingency hazardous chemotherapy compounding services for the Louis A. Johnson VA Medical Center. Should the inpatient pharmacy intravenous room at the medical center become non-operational, the selected vendor will be required to provide timely, safe, and compliant compounding of hazardous chemotherapy agents to ensure uninterrupted patient care. The services must be performed at the designated place of performance in Clarksburg, West Virginia, with a ZIP code of 26301, and the contract is governed under NAICS code 621610, which pertains to outpatient care centers specializing in medical services. The solicitation is open with a response deadline of August 14, 2026, and was posted on July 30, 2026. All proposals must be submitted through the SAM.gov portal using solicitation number 36C24526Q0652. The contracting office is located in Linthicum, Maryland, with Sylvia Honesty serving as the primary point of contact as Contract Specialist, reachable by phone at 410-642-2411 or via email at Sylvia.Honesty@va.gov. This solicitation does not designate a specific set-aside for small businesses or other categories and is open to all eligible contractors. The VA requires the contractor to adhere to strict regulatory standards for handling hazardous materials and maintaining the integrity of pharmaceutical compounding processes under emergency conditions. Contractors must demonstrate capacity for rapid deployment, compliance with federal and state pharmaceutical regulations, and the ability to meet the clinical and logistical demands of a federal medical facility during critical operational disruptions.